Mol Cell Biol, June 1998, p. 3368-3375, Vol. 18, No. 6
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
1(I) Collagen Gene

Departments of Biochemistry1 and Medicine,3 University of Washington, Seattle, Washington 98195, and The Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 021422
Received 27 January 1998/Accepted 10 March 1998
The role of the first intron of the Col1A1 gene in the
regulation of type I collagen synthesis remains uncertain and
controversial despite numerous studies that have made use of transgenic
and transfection experiments. To examine the importance of the first intron in regulation of the gene, we have used the double-replacement method of gene targeting to introduce, by homologous recombination in
embryonic stem (ES) cells, a mutated Col1A1 allele
(Col-Int
). The Col-Int
allele contains a 1.3-kb deletion within
intron I and is also marked by the introduction of a silent mutation
that created an XhoI restriction site in exon 7. Targeted
mice were generated from two independently derived ES cell clones. Mice carrying two copies of the mutated gene were born in the expected Mendelian ratio, developed normally, and showed no apparent
abnormalities. We used heterozygous mice to determine whether
expression of the mutated allele differs from that of the normal
allele. For this purpose, we developed a reverse transcription-PCR
assay which takes advantage of the XhoI polymorphism in
exon 7. Our results indicate that in the skin, and in cultured cells
derived from the skin, the intron plays little or no role in
constitutive expression of collagen I. However, in the lungs of young
mice, the mutated allele was expressed at about 75% of the level of
the normal allele, and in the adult lung expression was decreased to
less than 50%. These results were confirmed by RNase protection assays
which demonstrated a two- to threefold decrease in Col1A1
mRNA in lungs of homozygous mutant mice. Surprisingly, in cultured
cells derived from the lung, the mutated allele was expressed at a
level similar to that of the wild-type allele. Our results also
indicated an age-dependent requirement for the intact intron in
expression of the Col1A1 gene in muscle. Since the intron
is spliced normally, and since the mutant allele is expressed as well
as the wild-type allele in the skin, reduced mRNA stability is unlikely
to contribute to the reduction in transcript levels. We conclude that
the first intron of the Col1A1 gene plays a tissue-specific
and developmentally regulated role in transcriptional regulation of the
gene. Our experiments demonstrate the utility of gene-targeting
techniques that produce subtle mutations for studies of
cis-acting elements in gene regulation.
Present address: Department of Medical Biochemistry, University of
Turku, 20520 Turku, Finland.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|